Methods for prediction of clinical outcome to epidermal growth factor receptor inhibitors by non-small cell lung cancer patients

• 1. 一种非小细胞肺癌患者免疫治疗疗效预测方法及装置 [P] . 中国专利： CN113450920A . 2021-09-28
• 2. 预测非小细胞肺癌患者对药物的反应的方法 [P] . 中国专利： CN111094582A . 2020-05-01
• 3. Methods for the prediction of clinical outcome for inhibitors of the epidermal growth factor receptor in cancer patients [P] . ES2677562T3 . 2018-08-03

  机译： 预测癌症患者表皮生长因子受体抑制剂临床疗效的方法

• 4. METHODS FOR PREDICTION OF CLINICAL OUTCOME TO EPIDERMAL GROWTH FACTOR RECEPTOR INHIBITORS BY CANCER PATIENTS [P] . 欧洲知识产权局专利： EP2949764B1 . 2018-04-11

  机译： 癌症患者预测表皮生长因子受体抑制剂临床疗效的方法

• 5. METHODS FOR PREDICTION OF CLINICAL OUTCOME TO EPIDERMAL GROWTH FACTOR RECEPTOR INHIBITORS BY CANCER PATIENTS [P] . CA2567293C . 2017-05-16

  机译： 癌症患者预测表皮生长因子受体抑制剂临床疗效的方法

• 1. Clinical characteristics and response to tyrosine kinase inhibitors of patients with non-small cell lung cancer harboring uncommon epidermal growth factor receptor mutations [J] . Yan Zhang, Zheng Wang, Xuezhi Hao, 中国癌症研究（英文版） . 2017,第001期
• 2. Epidermal growth factor receptor mutation analysis in cytological specimens and responsiveness to gefitinib in advanced non-small cell lung cancer patients [J] . Lin Li, Zijin Zhang, Zhixin Bie, 中国癌症研究（英文版） . 2015,第003期
• 3. Relationship between epidermal growth factor receptor gene mutation and copy number in Chinese patients with non-small cell lung cancer [J] . Lan-Jun Zhang, Ling Cai, Zhe Li, 癌症（英文版） . 2012,第010期
• 4. Impact of clinical parameters and systemic inflammatory status on epidermal growth factor receptor-mutant non-small cell lung cancer patients readministration with epidermal growth factor receptor tyrosine kinase inhibitors [J] . Yu-Mu Chen, Chien-Hao Lai, Kun-Ming Rau, BMC Cancer . 2016,第1期
• 5. Current progress and outcomes of clinical trials on using epidermal growth factor receptor-tyrosine kinase inhibitor therapy in non-small cell lung cancer patients with brain metastases [J] . Ling-Ling Kong, Lin-Lin Wang, Li-Gang Xing, 慢性疾病与转化医学（英文） . 2017,第004期
• 6. Current progress and outcomes of clinical trials on using epidermal growth factor receptor-tyrosine kinase inhibitor therapy in non-small cell lung cancer patients with brain metastases [J] . Ling-Ling Kong, Lin-Lin Wang, Li-Gang Xing, 慢性疾病与转化医学：英文版 . 2017,第004期
• 7. Machine Learning-powered Prediction of Recurrence in Patients with Non-small Cell Lung Cancer Using Quantitative Clinical and Radiomic Biomarkers [C] . Sehwa Moon, Dahim Choi, Ji-Yeon Lee, Medical Imaging Conference . 2020
• 8. Unanticipated Effects of Tyrosine Kinase Inhibitors on Vitamin D Receptor Expression and Gene Regulation In Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Cancer. [D] . Timberlake, Alexandra F. 2017
• 9. Clinical management of epidermal growth factor receptor mutation-positive non-small cell lung cancer patients after progression on previous epidermal growth factor receptor tyrosine kinase inhibitors: the necessity of repeated molecular analysis [O] . José Luís González-Larriba, Martín Lázaro-Quintela, Manuel Cobo, 2017
• 10. Impact of clinical parameters and systemic inflammatory status on epidermal growth factor receptor-mutant non-small cell lung cancer patients readministration with epidermal growth factor receptor tyrosine kinase inhibitors [O] . Yu-Mu Chen, Chien-Hao Lai, Kun-Ming Rau, 2016

• 1. Is there a role for epidermal growth factor receptor tyrosine kinase inhibitors in epidermal growth factor receptor wildtype non-small cell lung cancer? [J] . Edurne Arriola ,lvaro Taus ,David Casadevall . 世界临床肿瘤学杂志：英文版 . 2015,第4期
• 2. Epidermal growth factor receptor tyrosine kinase inhibitors for non-small cell lung cancer [J] . Kazuhiro Asami ,Shinji Atagi . 世界临床肿瘤学杂志：英文版 . 2014,第4期
• 3. 喘可治注射液联合化疗对老年非小细胞肺癌患者免疫功能的影响及临床疗效 [C] . 朱可 ,陈汉锐 ,胡蓉 . 2017全国中医肿瘤学术大会 . 2017
• 4. 表皮生长因子受体酪氨酸激酶抑制剂（gefitinib）在中国晚期非小细胞肺癌患者中的疗效及安全性研究及临床疗效预测指标研究 [A] . 张晓彤 . 2005